11 studies found for:    intravenous immunoglobulin | alzheimer
Show Display Options
Rank Status Study
1 Completed Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Intravenous Immunoglobulin
2 Completed
Has Results
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Biological: octagam 10%
3 Recruiting A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: Albumin;   Biological: Immune globulin
4 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
5 Terminated Long-Term Study of IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Intervention: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%)
6 Active, not recruiting Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Intervention: Drug: NewGam 10% IVIG
7 Terminated Phase 3 IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution;   Biological: Human albumin 0.25%
8 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
9 Completed A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: GSK933776;   Drug: Placebo to match GSK933776
10 Completed A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
11 Active, not recruiting Continued Safety Monitoring of Solanezumab in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab

Indicates status has not been verified in more than two years